Nabi Biopharmaceuticals Announces Initiation Of Civacir(R) Phase II 'Proof-of- Concept' Clinical Trial
Wed, 17 Jan 2007 08:00 AM EST
... Nabi Biopharmaceuticals (Nasdaq: NABI) announced today that it has initiated its Phase II "proof-of-concept" clinical trial for Civacir(R) [Hepatitis C Immune Globulin (Human)]. [click link for full article] ...
Related Topics
- Clinical Trials
- Hepatitis B Immune Globulin
- Pharmacology
- Trastuzumab
- Psychopharmacology
- Tarceva
- Nystatin and Triamcinolone
- Food Recommendations: South Beach Diet - Phase 1
- Food Recommendations: South Beach Diet - Phase 2
- Idiot Proof Diet
- Bevacizumab Injection
- Clinical Growth Charts
- Crohn's Disease
- Pancreatic Cancer
- Patient Issues
- Kniest dysplasia
- Hypnotherapy
- Epidemiology
- Clinical Laboratory Improvement Amendments
- Depression

Not Signed In -


